Immunohistochemical identification of tissue factor in solid tumors

Area of Science:

• Oncology
• Hematology
• Biochemistry

Background:

• Cancer patients exhibit a higher incidence of thromboembolic disorders, known as Trousseau syndrome.
• The underlying cause of this cancer-associated hypercoagulable state remains largely unknown.
• Tissue factor (TF) expression on tumor cells is a potential mechanism contributing to thrombosis.

Purpose of the Study:

• To investigate the expression of tissue factor (TF) in a wide range of malignant tumors.
• To determine if TF expression correlates with the occurrence of Trousseau syndrome in cancer patients.
• To survey TF antigen localization in 85 diverse tumor specimens.

Main Methods:

• Immunohistochemical localization of TF antigen using a polyclonal, monospecific rabbit anti-human TF IgG.
• Analysis of 85 different tumor specimens, including epithelial and nonepithelial origins.
• Comparison of TF expression in malignant, benign, and normal tissues.

Main Results:

• TF expression was observed in 41 of 60 epithelial tumor specimens, consistent with normal tissue expression.
• Tumors of nonepithelial origin frequently lacked TF (only 3 of 19 positive).
• Benign tumors generally did not express TF (5 of 6 negative).
• Commonly associated cancers like lung, pancreatic, breast, colon, and gastric carcinomas showed positive TF staining.
• TF expression was detected in many tumor types linked to Trousseau syndrome.

Conclusions:

• Tumor cell expression of tissue factor (TF) is frequently observed in various carcinomas.
• TF expression by tumors may play a significant role in the pathogenesis of cancer-associated hypercoagulable states (Trousseau syndrome).
• Further research is warranted to elucidate the precise mechanisms linking TF to thrombosis in cancer.